Back to Atlas
digitaldiagnostics.com·Tracked since Jul 31, 2026

Digital Diagnostics

Mentions

1

Across all reports

Quality Score

15/ 100

New

First Seen

Jul 31, 2026

Indexed in atlas

Last Seen

7h ago

Most recent reference

Positioning

Synthesized from 1 mention

Digital Diagnostics' IDx-DR is the first FDA-authorized autonomous AI system for detecting diabetic retinopathy, operating without clinician interpretation. It integrates into primary care workflows, providing immediate results and referral recommendations. Its regulatory clearance and reimbursement support give it a strong commercial moat.

Strengths

4 cited
  • FDA clearance and reimbursement
  • Autonomous AI, no clinician interpretation
  • Strong clinical validation
  • Established distribution in US clinics

Weaknesses

3 cited
  • Hardware-dependent, not portable
  • Limited to diabetic retinopathy
  • US-centric, global expansion slow

Recent mentions

Showing 1 of 1
  • direct
    7h ago

    AI-Powered Retinal Disease Screening System

    poweredretinaldiseasescreeningsystem

Validate something like Digital Diagnostics

Use Digital Diagnostics as a starting point and let Unycorn map adjacent opportunities, underserved segments, and feature gaps worth pursuing.

Explore Collections

Curated sets of validated startup ideas, grouped by theme.